Welcome to PracticeUpdate! We hope you are enjoying access to a selection of our top-read and most recent articles. Please register today for a free account and gain full access to all of our expert-selected content.
Already Have An Account? Log in Now
Red Yeast Rice for Hypercholesterolemia
abstract
This abstract is available on the publisher's site.
Access this abstract nowThe extracts of red yeast rice (RYR) are currently the most effective cholesterol-lowering nutraceuticals. This activity is mainly due to monacolin K, a weak reversible inhibitor of 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase, whose daily consumption causes a reduction in low-density lipoprotein (LDL)-cholesterol plasma levels up to 15% to 25% within 6 to 8 weeks. The decrease in LDL-cholesterol is accompanied by a proportional decrease in total and non-high-density lipoprotein cholesterol, plasma apolipoprotein B, and high-sensitivity C-reactive protein. Some trials suggest that RYR use is associated with improvement in endothelial function and arterial stiffness, whereas a long-term study supports its role in the prevention of cardiovascular events. Despite the statin-like mechanism of action, the risk related to 3 to 10 mg monacolin K taken per day is minimal (mild myalgia in previously severely statin-intolerant subjects). RYR could represent a therapeutic tool to support lifestyle improvement in managing mild to moderate hypercholesterolemia in low-risk patients, including those who cannot be treated with statins or other LDL-cholesterol-lowering therapies.
Additional Info
Disclosure statements are available on the authors' profiles:
Red Yeast Rice for Hypercholesterolemia: JACC Focus Seminar
J Am Coll Cardiol 2021 Feb 09;77(5)620-628, AFG Cicero, F Fogacci, A ZambonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Primary Care
Red Yeast Rice for Hypercholesterolemia
When rice is steamed with the yeast Monascus purpureus it ferments, creating a red pigment that contains monacolin. Monacolin K is similar in chemical structure to lovastatin. In fact, the makers of lovastatin sued to prevent the marketing of red yeast rice (RYR), but they lost as nature has been making this chemical long before the statin industry.
Think of RYR as a mild statin that inhibits HMG-CoA reductase; but, for reasons unknown, RYR appears to be better tolerated than prescription statins with less associated myositis. Like statins, studies have found it to have other benefits beyond LDL reduction (Table 1).
The risk of these products is that they are not FDA-regulated, and the quality standards can vary. Most of the research has shown benefit from doses of monacolin K between 4 and 10 mg/day. But this is not standardized and rarely included on the label by manufacturers. The average dose is 1200 to 2400 mg daily, which generally contains this amount of monacolin K; but buyer beware.
In the fermentation process of RYR, a nephrotoxic, oncogenic chemical called citrinin can contaminate RYR supplements. Have patients buy products that are citrinin-free. A citrinin-free RYR product will cost about $20/month for 2400 mg daily.
There are good data on RYR showing cardiovascular outcomes similar to those achieved with low- to moderate-dose statins; but statins should be used first line for patients at high cardiovascular risk.
How To Prescribe RYR for Those Who Don’t Tolerate Statins or Don’t Want To Take One
RYR inhibits production of LDL. To reduce LDL further, consider adding one of the products below to also reduce cholesterol absorption.
Reference